SEATTLE and BALTIMORE -- The Bill & Melinda Gates Foundation will contribute $3 million to the Johns Hopkins University School of Medicine for the development of community-based preventive strategies to control tuberculosis (TB) in areas around the world with severe HIV epidemics. The grant will support the Consortium to Respond Effectively to the AIDS-Tuberculosis Epidemic (CREATE), a global initiative to combat the skyrocketing rates of sickness and death caused by these diseases.
"It is increasingly apparent that the HIV epidemic is rapidly undermining all existing methods of controlling TB," said Richard E. Chaisson, MD, professor of medicine, epidemiology and international health at Johns Hopkins and director of the Johns Hopkins Center for Tuberculosis Research. "CREATE will focus on developing innovative and effective public health strategies for controlling HIV-related TB."
"Because HIV increases the rate of active TB, it is important to address their co-infection," said Helene Gayle, director, HIV/AIDS & TB for the Bill & Melinda Gates Foundation. "Johns Hopkins is doing valuable work, driving the collaboration of scientists and field workers to develop new methods of controlling TB where HIV infection rates are high. These methods could ultimately serve as models for combating HIV/TB co-infection worldwide."
Strategies used by CREATE to control TB will involve entire communities in finding and treating undiagnosed TB cases in areas where rates of TB and HIV infection are soaring. In addition to assessing innovative approaches to control TB, CREATE will also evaluate the impact of HIV therapy on TB rates. The strategies will complement the World Health Organization DOTS strategy (Directly Observed Therapy, Short Course), which is based on passive detection of active TB cases.
Nearly 2 million people died from TB in 2000 alone, making TB the world's second leading killer among infectious diseases. More than 50 million people have been infected with HIV since the start of the epidemic, and there are an estimated 40 million people living with HIV infection today, the majority in sub-Saharan Africa. The World Health Organization estimates that one-quarter of all TB deaths occur in people with HIV and more than 10 million people with HIV infection died of TB in the 1990s.
The Bill & Melinda Gates Foundation is dedicated to improving people's lives by sharing advances in health and learning with the global community. Led by Bill Gates' father, William H. Gates, Sr., and Patty Stonesifer, the Seattle-based foundation has an endowment of approximately $24 billion.
Johns Hopkins is one of the world's premier centers for scholarship, research and patient care. The university and The Johns Hopkins Health System are separate, but closely allied, institutions. Founded in Baltimore, they now reach across the Baltimore-Washington area, with additional facilities in China, Italy and Singapore and partnerships around the world. The university comprises eight schools, a research and development division called the Applied Physics Laboratory and a number of institutes and centers.
Source: PRNewswire
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.